Takeshita A - Search Results

1

All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.

Ohno R, Ohnishi K, Takeshita A, Tanimoto M, Murakami H, Kanamaru A, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, et al. Ohno R, et al. Among authors: takeshita a. Leukemia. 1994;8 Suppl 3:S64-9. Leukemia. 1994. PMID: 7808028 Clinical Trial.

2

[A randomized double-blind controlled study of recombinant human granulocyte colony-stimulating factor in patients with neutropenia induced by consolidation chemotherapy for acute myeloid leukemia. (rG.CSF clinical study group)].

Takeshita A, Ohno R, Hirashima K, Toyama K, Okuma M, Saito H, Ikeda Y, Tomonaga M, Asano S. Takeshita A, et al. Rinsho Ketsueki. 1995 Jun;36(6):606-14. Rinsho Ketsueki. 1995. PMID: 7543956 Clinical Trial. Japanese.

3

New flow cytometric method for detection of minimally expressed multidrug resistance P-glycoprotein on normal and acute leukemia cells using biotinylated MRK16 and streptavidin-RED670 conjugate.

Takeshita A, Shinjo K, Ohnishi K, Ohno R. Takeshita A, et al. Jpn J Cancer Res. 1995 Jun;86(6):607-15. doi: 10.1111/j.1349-7006.1995.tb02441.x. Jpn J Cancer Res. 1995. PMID: 7622426 Free PMC article.

4

Expression of granulocyte colony-stimulating factor receptor increases with differentiation in myeloid cells by a newly-devised quantitative flow-cytometric assay.

Shinjo K, Takeshita A, Ohnishi K, Ohno R. Shinjo K, et al. Among authors: takeshita a. Br J Haematol. 1995 Dec;91(4):783-94. doi: 10.1111/j.1365-2141.1995.tb05390.x. Br J Haematol. 1995. PMID: 8547119

5

Successful treatment of relapse of acute promyelocytic leukemia with a new synthetic retinoid, Am80.

Takeshita A, Shibata Y, Shinjo K, Yanagi M, Tobita T, Ohnishi K, Miyawaki S, Shudo K, Ohno R. Takeshita A, et al. Ann Intern Med. 1996 May 15;124(10):893-6. doi: 10.7326/0003-4819-124-10-199605150-00006. Ann Intern Med. 1996. PMID: 8610919 No abstract available.

6

Expression of multidrug resistance P-glycoprotein in myeloid progenitor cells of different phenotype: comparison between normal bone marrow cells and leukaemia cells.

Takeshita A, Shinjo K, Ohnishi K, Ohno R. Takeshita A, et al. Br J Haematol. 1996 Apr;93(1):18-21. doi: 10.1046/j.1365-2141.1996.459996.x. Br J Haematol. 1996. PMID: 8611458

7

Significant reduction of medical costs by differentiation therapy with all-trans retinoic acid during remission induction of newly diagnosed patients with acute promyelocytic leukemia. The Japan Adult Leukemia Study Group.

Takeshita A, Sakamaki H, Miyawaki S, Kobayashi T, Kuriyama K, Yamada O, Oh H, Takenaka T, Asou N, Ohno R. Takeshita A, et al. Cancer. 1995 Aug 15;76(4):602-8. doi: 10.1002/1097-0142(19950815)76:4<602::aid-cncr2820760410>3.0.co;2-l. Cancer. 1995. PMID: 8625153

8

[Efficacy of early administration of G-CSF after intensive chemotherapy in acute leukemia: a randomized controlled trial. Tokai Infection Study Group on Hematological Disorders].

Takeyama H, Yamada H, Emi N, Saito H, Takeshita A, Ohno R, Yoshida H, Naoe T, Kageyama S, Shirakawa S, et al. Takeyama H, et al. Among authors: takeshita a. Rinsho Ketsueki. 1995 Nov;36(11):1257-65. Rinsho Ketsueki. 1995. PMID: 8691565 Clinical Trial. Japanese.

9

Vincristine treatment of severe thrombocytopenia in paroxysmal nocturnal hemoglobinuria.

Takeshita A, Ohnishi K, Ohno R. Takeshita A, et al. Ann Intern Med. 1996 Sep 1;125(5):424. doi: 10.7326/0003-4819-125-5-199609010-00027. Ann Intern Med. 1996. PMID: 8702105 No abstract available.

10

[Multidrug resistance in acute leukemia].

Takeshita A, Ohno R. Takeshita A, et al. Rinsho Ketsueki. 1996 Aug;37(8):640-6. Rinsho Ketsueki. 1996. PMID: 8827870 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,026 results

Search Page

Filters